Rejuve.AI
PrivateLast Round
Token Sale
Mar 16, 2023
Est. Valuation
$15M
Total Funding Raised
$750,000
Company Overview
Rejuve.AI operates in Healthcare & Life Sciences and is based in Saint Lucia. Its latest recorded funding round was a Token Sale round in March 2023.
Rejuve.AI is a biotechnology and artificial intelligence company that operates a decentralized longevity research network and mobile application for health data tracking and analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Healthcare Analytics, Tokenization, Precision Medicine
Business Model
B2C
Customer Profile
Data as a Service, Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuve.AI Comparables
Compare Rejuve.AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humanity Inc. | 78% | |
| 360Me | 76% | |
| CUDIS | 75% |
For institutional investors. Book with your work email.
Rejuve.AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Token Sale | Mar 16, 2023 | ||||
| Private Equity | Feb 1, 2023 | ||||
| Seed | Oct 1, 2022 |
For institutional investors. Book with your work email.
Rejuve.AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAO Maker | Token Sale |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 466% MoM to 45.4K.
- Mar 3, 2026
Monthly visitors grew 132% MoM, reaching 8K.
For institutional investors. Book with your work email.
Rejuve.AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rejuve.AI's valuation, stock price, and market status.
Is Rejuve.AI a public or private company?
Rejuve.AI is a private company.
What is the current stock price of Rejuve.AI?
Rejuve.AI is a private company, so its shares have no public market price. Caplight tracks Rejuve.AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rejuve.AI worth (valuation)?
Rejuve.AI's valuation is estimated at $15.0M based on funding round data.
Can I buy Rejuve.AI stock?
Rejuve.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rejuve.AI's last funding round?
Rejuve.AI's most recent funding round was Token Sale on March 16, 2023.
Who are the main investors in Rejuve.AI?
Key investors in Rejuve.AI include DAO Maker.
Will Rejuve.AI IPO soon?
No public IPO plans have been announced for Rejuve.AI.
How can I track Rejuve.AI secondary market activity?
Caplight tracks bids, offers, and trades in Rejuve.AI's shares on secondary markets.